Back
Brainstorm Cell Therapeutics Vs. Outlook Therapeutics Industry Stock Comparison
Sell
10
BCLI
Brainstorm Cell Therapeutics
Last Price:
1.87
Seasonality Move:
2.27%
Sell
25
OTLK
Outlook Therapeutics
Last Price:
5.76
Seasonality Move:
-12.63%
Sell
10
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $1.87. The Score for BCLI is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics a Buy, Sell or Hold?
- The current Outlook Therapeutics [OTLK] share price is $5.77. The Score for OTLK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- OTLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $1.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
OTLK Stock Price Chart
What is Outlook Therapeutics's stock price today?
-
The Outlook Therapeutics share price today is $5.77
The current trend is relatively stagnant and OTLK is experiencing slight selling pressure.
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 30.53 | Sell |
| Chaikin Money Flow: | -6697 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.82 - 2.88) | Sell |
| Bollinger Bands (100): | (2.96 - 5.76) | Sell |
OTLK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 54.54 | Buy |
| Chaikin Money Flow: | 8811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.97 | Sell |
| 20-day SMA: | 2.11 | Sell |
| 50-day SMA: | 3.3 | Sell |
| 200-day SMA: | 5.56 | Sell |
| 8-day EMA: | 1.99 | Sell |
| 20-day EMA: | 2.27 | Sell |
| 50-day EMA: | 3.11 | Sell |
| 200-day EMA: | 6.38 | Sell |
OTLK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.57 | Buy |
| 20-day SMA: | 5.32 | Buy |
| 50-day SMA: | 6.14 | Sell |
| 200-day SMA: | 7.55 | Sell |
| 8-day EMA: | 5.57 | Buy |
| 20-day EMA: | 5.53 | Buy |
| 50-day EMA: | 6.01 | Sell |
| 200-day EMA: | 8.2 | Sell |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.
Outlook Therapeutics Earnings Growth & OTLK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.
Brainstorm Cell Therapeutics Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Outlook Therapeutics Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||